Pharmacokinetics of the enantiomers of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma, urine and cerebrospinal fluid

Journal of Drug Development and Clinical Practice

Volumn 7, Issue 1, 1996, Pages 319-326

  Kaijser, G R ^a   Beijnen, J H ^b   Keizer, H J ^c   De Kraker, J ^d   Bult, A ^b   Underberg, W J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adults; Bio analysis; Children; Enantiomers; Ifosfamide; Pharmacokinetics

Indexed keywords

DRUG DERIVATIVE; IFOSFAMIDE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG URINE LEVEL; ENANTIOMER; FEMALE; GAS CHROMATOGRAPHY; GENDER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0030041238     PISSN: 13579215     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Crom WR. Am J Hosp Pharm 1992;49:S9-15.
2. Cox PJ, Farmer PB, Jarman M, et al. Biochem Pharmacol 1976;25:993-996.
3. Kusnierczyk H, Radzikowski C, Paprocka M, et al. J Immunopharmacol 1986;8:455-480.
4. Blaschke G, Widey W Arzneimittelforschung 1986;36:1493-1495.
5. Masurel D, Houghton PJ, Young CL, Wainer I. Cancer Res 1990:50:252-255.
6. Cox PJ, Farmer PB, Jarman M, et al. Drug Metab Dispos Bio Fate Chem 1978;6:617-622.
7. Farmer PB. Biochem Pharmacol 1988:37:145-148.
8. Jarman M, Milsted RAV, Smyth JF, et al. Cancer Res 1979:39:2762-2767.
9. Misiura K, Okruszek A, Pankeiwicz K, et al. Med Chem 1983:26:674-679.
10. Allen LM, Creaven PJ. Cancer Chemother Rep 1972:56:721-723.
11. Brade WP, Herdnch K, Varmi M. Cancer Treat Rev 1985:12:1-47.
12. Bryant BM, Jarman M, Baker MH, Smith IE. Cancer Res 1980:40:4734-4738.
13. Burton LC, James CA.J Chromatogr 1988:431:450-454
14. Colvin M. Semin Oncol 1982:9:2-7.
15. Creaven PJ, Allen LM, Alford DA, Cohen MR Clin Pharmacol Ther 1974;16:77-86.
16. Wainer IW, Stewart CF, Young CL, et al. Proc Am Soc Clin Oncol 1988;7:72.
17. Koch U, Blaschke G. Sci Pharm 1986;54:202.
18. Masurel D, Wainer IW. J Chromatogr 1989;490:133-143.
19. Widey W, Blaschke G. Sci Pharm 1986;54:287.
20. Young CL, FrankJ, Stewart CF, Wainer IW. Chirality 1989;l:235-238.
21. Boos J, Welslau U, Ritter J, étal. Cancer Chemother Pharmacol 1991;28:455-460.
22. Kaijser GP, Beijnen JH, Buk A, et al. J Chromatogr 1991;571:121-131.
23. Kaijser GP, Beijnen JH, Buk A, et al. J Chromatogr 1992;583:175-182.